| Normal | VS | VE | p-value | Adjusted p-value |
---|---|---|---|---|---|
Age of first symptoms | 27.77 (6.83) | 23.90 (6.50) | 27.72 (7.45) | 0.0726 | 0.7109 |
Duration of untreated psychosis (months)* | 7.03 (14.08) | 3.05 (7.53) | 6.74 (7.58) | 0.1220 | 0.7320 |
Chlorpromazine equivalent V1* | 379.37 (244.50) | 376.21 (196.06) | 344.40 (131.19) | 0.8331 | 1.0000 |
Chlorpromazine equivalent V2* | 264.82 (191.41) | 311.57 (161.71) | 315.80 (212.86) | 0.3744 | 1.0000 |
PANSS - P V1* | 12.19 (3.99) | 12.74 (3.51) | 14.65 (4.72) | 0.0821 | 0.7109 |
PANSS - N V1 | 17.06 (4.93) | 19.79 (7.76) | 17.55 (5.38) | 0.5453 | 1.0000 |
PANSS - G V1 | 30.26 (7.58) | 35.79 (8.43) | 34.00 (7.30) | 0.0161 | 0.2099 |
PANSS total V1* | 59.51 (13.82) | 68.32 (17.31) | 66.20 (14.66) | 0.0711 | 0.7109 |
PANSS - P V2* | 9.89 (3.57) | 9.37 (3.18) | 11.76 (4.93) | 0.1297 | 0.7320 |
PANSS - N V2* | 14.55 (5.42) | 13.89 (5.65) | 17.95 (5.31) | 0.0327 | 0.3903 |
PANSS - G V2* | 25.73 (6.94) | 25.26 (6.44) | 31.90 (8.79) | 0.0127 | 0.1773 |
PANSS total V2* | 59.51 (13.82) | 68.32 (17.31) | 66.20 (14.66) | 0.0711 | 0.7109 |
GAF V1 | 65.27 (15.24) | 58.22 (16.96) | 60.38 (18.59) | 0.2282 | 0.9126 |
GAF V2* | 75.36 (14.93) | 75.84 (12.53) | 66.86 (14.17) | 0.0325 | 0.3903 |